{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:44:56Z","timestamp":1792784696366,"version":"4.5.0"},"reference-count":39,"publisher":"American Chemical Society (ACS)","issue":"20","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"name":"Lingang Laboratory"},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23PJ1430100"],"award-info":[{"award-number":["23PJ1430100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LY22H160016"],"award-info":[{"award-number":["LY22H160016"]}],"id":[{"id":"https:\/\/ror.org\/04aqat463","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Discipline Cluster of Oncology, Wenzhou Medical University","award":["z2-2023016"],"award-info":[{"award-number":["z2-2023016"]}],"id":[{"id":"https:\/\/ror.org\/00rd5t069","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The clinical management of glioblastoma (GBM) is severely hindered by rapid resistance to temozolomide (TMZ). Through viability-based phenotypic screening, we identified the translation termination factor GSPT1 (G1 to S phase transition 1) as a critical vulnerability in GBM cells. Structure\u2212activity relationship optimization of an isoindolinone scaffold, specifically focused on improving metabolic stability, led to the discovery of LG-NE-29, a potent molecular glue degrader. This compound efficiently promotes CRBN-dependent ubiquitination and subsequent proteasomal degradation of GSPT1. LG-NE-29 overcomes the metabolic liabilities of early-generation scaffolds, exhibiting an optimized pharmacokinetic profile highlighted by excellent oral bioavailability (F = 76%). Mechanistically, GSPT1 depletion triggers a profound integrated stress response and intrinsic apoptosis. In U87MG xenograft models, oral administration of LG-NE-29 induced significant tumor regression. Collectively, these findings validate GSPT1 as an actionable therapeutic target in GBM and establish LG-NE-29 as a robust pharmacological tool for further targeted protein degradation research.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c00544","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:02:08Z","timestamp":1791050528000},"page":"23540-23563","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of LG-NE-29: An Orally Bioavailable GSPT1 Molecular Glue Degrader Effective in Glioblastoma Xenograft Models"],"prefix":"10.1021","volume":"69","author":[{"given":"Taiting","family":"Shi","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Wenzhou Medical University , , ,","place":["Wenzhou, China, 325000"]},{"name":"Lingang Laboratory , ,","place":["Shanghai, China, 200031"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Pei","sequence":"additional","affiliation":[{"name":"Lingang Laboratory , ,","place":["Shanghai, China, 200031"]},{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Peng","sequence":"additional","affiliation":[{"name":"Lingang Laboratory , ,","place":["Shanghai, China, 200031"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerui","family":"Wu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Wenzhou Medical University , , ,","place":["Wenzhou, China, 325000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Feng","sequence":"additional","affiliation":[{"name":"Lingang Laboratory , ,","place":["Shanghai, China, 200031"]},{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[{"name":"Lingang Laboratory , ,","place":["Shanghai, China, 200031"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyu","family":"Luo","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Wenzhou Medical University , , ,","place":["Wenzhou, China, 325000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[{"name":"Lingang Laboratory , ,","place":["Shanghai, China, 200031"]},{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyan","family":"Chen","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Wenzhou Medical University , , ,","place":["Wenzhou, China, 325000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Wenzhou Medical University , , ,","place":["Wenzhou, China, 325000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Shao","sequence":"additional","affiliation":[{"name":"Lingang Laboratory , ,","place":["Shanghai, China, 200031"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Liu","sequence":"additional","affiliation":[{"name":"Lingang Laboratory , ,","place":["Shanghai, China, 200031"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5391-1434","authenticated-orcid":true,"given":"Xueying","family":"Gong","sequence":"additional","affiliation":[{"name":"Lingang Laboratory , ,","place":["Shanghai, China, 200031"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuke","family":"Yang","sequence":"additional","affiliation":[{"name":"Lingang Laboratory , ,","place":["Shanghai, China, 200031"]},{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Zou","sequence":"additional","affiliation":[{"name":"Lingang Laboratory , ,","place":["Shanghai, China, 200031"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Tongji University , , ,","place":["Shanghai, China, 200092"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[{"name":"Lingang Laboratory , ,","place":["Shanghai, China, 200031"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hewei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Lingang Laboratory , ,","place":["Shanghai, China, 200031"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlong","family":"Xu","sequence":"additional","affiliation":[{"name":"Lingang Laboratory , ,","place":["Shanghai, China, 200031"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8541-8210","authenticated-orcid":true,"given":"Zhanchao","family":"Meng","sequence":"additional","affiliation":[{"name":"Lingang Laboratory , ,","place":["Shanghai, China, 200031"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1175-365X","authenticated-orcid":true,"given":"Wenchao","family":"Lu","sequence":"additional","affiliation":[{"name":"Lingang Laboratory , ,","place":["Shanghai, China, 200031"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Su","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Wenzhou Medical University , , ,","place":["Wenzhou, China, 325000"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"issue":"9","key":"2026102305075455100_cit1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/01.cot.0000289242.47980.f9","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"27","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"2026102305075455100_cit2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3322\/caac.21693","article-title":"Brain and other central nervous system tumor statistics, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2026102305075455100_cit3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"issue":"12","key":"2026102305075455100_cit4","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/j.cell.2022.04.038","article-title":"Glioma progression is shaped by genetic evolution and microenvironment interactions","volume":"185","author":"Varn","year":"2022","journal-title":"Cell"},{"issue":"1","key":"2026102305075455100_cit5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cell.2020.12.020","article-title":"The Rise of Molecular Glues","volume":"184","author":"Schreiber","year":"2021","journal-title":"Cell"},{"issue":"3","key":"2026102305075455100_cit6","doi-asserted-by":"publisher","first-page":"100422","DOI":"10.1016\/j.xinn.2023.100422","article-title":"Targeted protein degradation bypassing cereblon and von Hippel-Lindau","volume":"4","author":"Lu","year":"2023","journal-title":"Innovation"},{"issue":"6168","key":"2026102305075455100_cit7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kro\u0308nke","year":"2014","journal-title":"Science"},{"issue":"6168","key":"2026102305075455100_cit8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science"},{"key":"2026102305075455100_cit9","doi-asserted-by":"publisher","DOI":"10.1002\/anie.1973691","article-title":"Selective and Potent First-in-Class CRBN-Dependent Molecular Glue Degraders of WW Domain-Binding Protein 4","volume":"65","author":"Liu","year":"2026","journal-title":"Angew. Chem. Int. Ed."},{"issue":"7","key":"2026102305075455100_cit10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41568-025-00817-8","article-title":"Targeted protein degradation for cancer therapy","volume":"25","author":"Hinterndorfer","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"2026102305075455100_cit11","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41580-024-00729-9","article-title":"Targeted protein degradation: from mechanisms to clinic","volume":"25","author":"Tsai","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"2026102305075455100_cit12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.tibs.2025.07.005","article-title":"Exploring nondegrading molecular glues for protein-protein interactions","volume":"50","author":"Yu","year":"2025","journal-title":"Trends Biochem. Sci."},{"issue":"7611","key":"2026102305075455100_cit13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nature18611","article-title":"A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase","volume":"535","author":"Matyskiela","year":"2016","journal-title":"Nature"},{"issue":"6","key":"2026102305075455100_cit14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/wrna.1133","article-title":"Mechanism of the initiation of mRNA decay: role of eRF3 family G proteins","volume":"3","author":"Hoshino","year":"2012","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"47","key":"2026102305075455100_cit15","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202511789","article-title":"Cancer Biology of GSPT1: Mechanisms and Targeted Therapy Opportunities of Molecular Glue Degraders","volume":"12","author":"Lin","year":"2025","journal-title":"Adv Sci."},{"key":"2026102305075455100_cit16","doi-asserted-by":"publisher","first-page":"118390","DOI":"10.1016\/j.bmc.2025.118390","article-title":"GSPT1 degraders: research progress, development strategies and challenges","volume":"131","author":"Liu","year":"2025","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"2026102305075455100_cit17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1182\/blood.2020008676","article-title":"CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells","volume":"137","author":"Surka","year":"2021","journal-title":"Blood"},{"issue":"8","key":"2026102305075455100_cit18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41419-024-06967-1","article-title":"Potential of GSPT1 as a novel target for glioblastoma therapy","volume":"15","author":"Sasayama","year":"2024","journal-title":"Cell Death Dis."},{"issue":"8","key":"2026102305075455100_cit19","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrd.2017.111","article-title":"Opportunities and challenges in phenotypic drug discovery: an industry perspective","volume":"16","author":"Moffat","year":"2017","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"17","key":"2026102305075455100_cit20","doi-asserted-by":"publisher","first-page":"18024","DOI":"10.1021\/acs.jmedchem.5c00949","article-title":"Phenotypic Screening for Targeted Protein Degradation: Strategies, Challenges, and Emerging Opportunities","volume":"68","author":"Ding","year":"2025","journal-title":"J. Med. Chem."},{"issue":"12","key":"2026102305075455100_cit21","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nn.3554","article-title":"The microglial sensome revealed by direct RNA sequencing","volume":"16","author":"Hickman","year":"2013","journal-title":"Nat. Neurosci."},{"key":"2026102305075455100_cit22","doi-asserted-by":"publisher","first-page":"101214","DOI":"10.1016\/j.drup.2025.101214","article-title":"Centromere protein U mediates the ubiquitination and degradation of RPS3 to facilitate temozolomide resistance in glioblastoma","volume":"80","author":"Sun","year":"2025","journal-title":"Drug Resist. Updates"},{"issue":"7512","key":"2026102305075455100_cit23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature13527","article-title":"Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide","volume":"512","author":"Fischer","year":"2014","journal-title":"Nature"},{"issue":"8","key":"2026102305075455100_cit24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","article-title":"Mechanisms, regulation and functions of the unfolded protein response","volume":"21","author":"Hetz","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"2026102305075455100_cit25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1042\/ebc20170041","article-title":"Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders","volume":"61","author":"Hughes","year":"2017","journal-title":"Essays Biochem."},{"issue":"7","key":"2026102305075455100_cit26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1182\/blood.2022017813","article-title":"The orally bioavailable GSPT1\/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemia","volume":"142","author":"Chang","year":"2023","journal-title":"Blood"},{"issue":"5","key":"2026102305075455100_cit27","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/s1097-2765(00)00108-8","article-title":"Regulated translation initiation controls stress-induced gene expression in mammalian cells","volume":"6","author":"Harding","year":"2000","journal-title":"Mol. Cell"},{"issue":"6059","key":"2026102305075455100_cit28","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: from stress pathway to homeostatic regulation","volume":"334","author":"Walter","year":"2011","journal-title":"Science"},{"key":"2026102305075455100_cit29","unstructured":"Fasching, B.; Ryckmans, T.; Ritze\u0301n, A.; Oleinikovas, V.\n          Compounds That Mediate Protein Degradation and Methods of Use Thereof. WO 2023069720 A12023."},{"key":"2026102305075455100_cit30","unstructured":"Kulyk, S.; Smith, C. R.; Ivetac, A.; Lawson, J. D.\n          2-Amino Imidazole Derivatives. 2023, WO 2023081367 A2."},{"key":"2026102305075455100_cit31","unstructured":"Yang, Z.; Liu, S.; Pan, J.; Chen, D.; Xu, R.; Ma, L.; Tong, Y.\n          Multi-Protein Degradation Agent Having Imide Skeleton, 2023; WO 2023116835 A1."},{"issue":"4","key":"2026102305075455100_cit32","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1021\/acs.jmedchem.2c01941","article-title":"Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation","volume":"66","author":"Xie","year":"2023","journal-title":"J. Med. Chem."},{"key":"2026102305075455100_cit33","unstructured":"Muller, G. W.\n            \n              Man, H.-W.\n          \n          6-, 7-, or 8-Substituted Quinazolinone Derivatives and Compositions Comprising and Methods of Using the Same. US 20,090,093,504 A1, 2009."},{"key":"2026102305075455100_cit34","unstructured":"Winter, C.; Rheinheimer, J.; Wolf, A.; Terteryan, V.; Poonoth, M.; Wiebe, C.; Kremzow-Graw, D.; Ro\u0308hl, F.; Rohrer, S. G.; Wieja, A.; Rosenbaum, C.; Grammenos, W.\n          Strobilurin Type Compounds for Combating Phytopathogenic Fungi, 2014. WO 2014202703 A1."},{"key":"2026102305075455100_cit35","unstructured":"O\u2019Brien, T. E.; Smith, R. T.; Verma, V. A.; Villemure, E.; Barton, L. M.; Huestis, M.; Zhou, Y.; Wong, A. R.\n          Degraders of Cyclin-Dependent Kinase 2. WO 2025043225 A2, 2025."},{"issue":"12","key":"2026102305075455100_cit36","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1038\/s41596-020-0402-9","article-title":"Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing","volume":"15","author":"Jacob","year":"2020","journal-title":"Nat. Protoc."},{"issue":"48","key":"2026102305075455100_cit37","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202503277","article-title":"Discovery of a Potent and Selective TEAD Degrader with Durable Degradation Activity","volume":"12","author":"Cao","year":"2025","journal-title":"Adv Sci."},{"issue":"12","key":"2026102305075455100_cit38","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202500169","article-title":"Selective and Potent Molecular Glue Degraders for NIMA-Related Kinase 7","volume":"64","author":"Chen","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"issue":"11","key":"2026102305075455100_cit39","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1021\/jacsau.4c00762","article-title":"Development of Oral, Potent, and Selective CK1alpha Degraders for AML Therapy","volume":"4","author":"Huang","year":"2024","journal-title":"JACS Au"}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c00544","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/23540\/68740047\/jm6c00544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/23540\/68740047\/jm6c00544.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:16:30Z","timestamp":1792746990000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/20\/23540\/5444242\/Discovery-of-LG-NE-29-An-Orally-Bioavailable-GSPT1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":39,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2026,10,3]]},"published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c00544","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]}}}